Literature DB >> 18537959

Exenatide may aggravate moderate diabetic renal impairment: a case report.

Odd Erik Johansen, Rolf Whitfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18537959      PMCID： PMC2561107          DOI： 10.1111/j.1365-2125.2008.03221.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population.

Authors:  G T Obrador; P Arora; A T Kausz; R Ruthazer; B J Pereira; A S Levey
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin.

Authors:  Prabhakar Viswanathan; Ajay Chaudhuri; Ruchi Bhatia; Fida Al-Atrash; Priya Mohanty; Paresh Dandona
Journal:  Endocr Pract       Date:  2007-09       Impact factor: 3.443

4.  Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.

Authors:  Catherine A Sheffield; Michael P Kane; Robert S Busch
Journal:  Pharmacotherapy       Date:  2007-10       Impact factor: 4.705

5.  Effect of renal impairment on the pharmacokinetics of exenatide.

Authors:  Helle Linnebjerg; Prajakti A Kothare; Soomin Park; Kenneth Mace; Shobha Reddy; Malcolm Mitchell; Robert Lins
Journal:  Br J Clin Pharmacol       Date:  2007-04-10       Impact factor: 4.335
  5 in total
  9 in total

Review 1.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

Review 2.  Adverse Effects of GLP-1 Receptor Agonists.

Authors:  Theodosios D Filippatos; Thalia V Panagiotopoulou; Moses S Elisaf
Journal:  Rev Diabet Stud       Date:  2015-02-10

3.  Acute renal failure when exenatide is co-administered with diuretics and angiotensin II blockers.

Authors:  Alfonso López-Ruiz; Cristina del Peso-Gilsanz; Amparo Meoro-Avilés; José Soriano-Palao; Alberto Andreu; Juan Cabezuelo; José L Arias
Journal:  Pharm World Sci       Date:  2010-08-05

Review 4.  Pharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2015-01       Impact factor: 6.447

5.  Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

Authors:  Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

Review 6.  Effects of glucagon-like peptide-1 receptor agonists on renal function.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Diabetes       Date:  2013-10-15

Review 7.  Management of post-transplant diabetes.

Authors:  Ashley Therasse; Amisha Wallia; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

8.  Management of diabetes mellitus in patients with chronic kidney disease.

Authors:  Allison J Hahr; Mark E Molitch
Journal:  Clin Diabetes Endocrinol       Date:  2015-06-04

Review 9.  Hypoglycemia in Patients with Diabetes and Renal Disease.

Authors:  Mazen Alsahli; John E Gerich
Journal:  J Clin Med       Date:  2015-05-13       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.